Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982–3021.

Article  PubMed  PubMed Central  Google Scholar 

Scafa Udriste A, Niculescu AG, Grumezescu AM, Bădilă E. Cardiovascular stents: a review of past, current, and emerging devices. Materials. 2021;14:2498.

Article  PubMed  PubMed Central  Google Scholar 

Nicolas J, Pivato CA, Chiarito M, Beerkens F, Cao D, Mehran R. Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside. Cardiovasc Res. 2023;119:631–46.

Article  CAS  PubMed  Google Scholar 

Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978;1:263.

Article  CAS  PubMed  Google Scholar 

Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489–95.

Article  CAS  PubMed  Google Scholar 

Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994;331:496–501.

Article  CAS  PubMed  Google Scholar 

Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JW, et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation. 1991;83:148–61.

Article  CAS  PubMed  Google Scholar 

Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005;294:1215–23.

Article  CAS  PubMed  Google Scholar 

Oh S, Hyun DY, Cho KH, Kim JH, Jeong MH. Long-term outcomes in ST-elevation myocardial infarction patients treated according to hospital visit time. Korean J Intern Med. 2022;37:605–17.

Article  PubMed  Google Scholar 

Habib A, Finn AV. Endothelialization of drug eluting stents and its impact on dual anti-platelet therapy duration. Pharmacol Res. 2015;93:22–7.

Article  CAS  PubMed  Google Scholar 

Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193–202.

Article  PubMed  Google Scholar 

Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435–41.

Article  PubMed  Google Scholar 

Kim HS, Kang J, Hwang D, Han JK, Yang HM, Kang HJ, et al. Durable polymer versus biodegradable polymer drug-eluting stents after percutaneous coronary intervention in patients with acute coronary syndrome: the host-reduce-polytech-acs trial. Circulation. 2021;143:1081–91.

Article  CAS  PubMed  Google Scholar 

Mashaghi A, Marmalidou A, Tehrani M, Grace PM, Pothoulakis C, Dana R. Neuropeptide substance P and the immune response. Cell Mol Life Sci. 2016;73:4249–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Redkiewicz P. The regenerative potential of substance P. Int J Mol Sci. 2022;23:750.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Suvas S. Role of substance P neuropeptide in inflammation, wound healing, and tissue homeostasis. J Immunol. 2017;199:1543–52.

Article  CAS  PubMed  Google Scholar 

Zieglgansberger W. Substance P and pain chronicity. Cell Tissue Res. 2019;375:227–41.

Article  CAS  PubMed  Google Scholar 

Katsanos GS, Anogeianaki A, Orso C, Tete S, Salini V, Antinolfi PL, et al. Impact of substance P on cellular immunity. J Biol Regul Homeost Agents. 2008;22:93–8.

CAS  PubMed  Google Scholar 

Castellani ML, Galzio RJ, Felaco P, Tripodi D, Toniato E, De Lutiis MA, et al. VEGF, substance P and stress, new aspects: a revisited study. J Biol Regul Homeost Agents. 2010;24:229–37.

CAS  PubMed  Google Scholar 

Kohara H, Tajima S, Yamamoto M, Tabata Y. Angiogenesis induced by controlled release of neuropeptide substance P. Biomaterials. 2010;31:8617–25.

Article  CAS  PubMed  Google Scholar 

Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest. 1997;99:2625–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mouritzen MV, et al. Neurotensin, substance P, and insulin enhance cell migration. J Pept Sci. 2018;24: e3093.

Article  PubMed  Google Scholar 

Liu Y, Munisso MC, Mahara A, Kambe Y, Yamaoka T. Anti-platelet adhesion and in situ capture of circulating endothelial progenitor cells on ePTFE surface modified with poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC) and hemocompatible peptide 1 (HCP-1). Colloids Surf B Biointerfaces. 2020;193:111113.

Article  CAS  PubMed  Google Scholar 

Xu Y, Takai M, Ishihara K. Protein adsorption and cell adhesion on cationic, neutral, and anionic 2-methacryloyloxyethyl phosphorylcholine copolymer surfaces. Biomaterials. 2009;30:4930–8.

Article  CAS  PubMed  Google Scholar 

Moro T, Takatori Y, Ishihara K, Konno T, Takigawa Y, Matsushita T, et al. Surface grafting of artificial joints with a biocompatible polymer for preventing periprosthetic osteolysis. Nat Mater. 2004;3:829–36.

Article  CAS  PubMed  Google Scholar 

Ranucci M, Isgrò G, Soro G, Canziani A, Menicanti L, Frigiola A. Reduced systemic heparin dose with phosphorylcholine coated closed circuit in coronary operations. Int J Artif Organs. 2004;27:311–9.

Article  CAS  PubMed  Google Scholar 

Ueda T, Oshida H, Kurita K, Ishihara K, Nakabayashi N. Preparation of 2-methacryloyloxyethyl phosphorylcholine copolymers with Alkyl Methacrylates and their blood compatibility. Polym J. 1992;24:1259–69.

Article  CAS  Google Scholar 

Xie R, Tian Y, Peng S, Zhang L, Men Y, Yang W. Poly(2-methacryloyloxyethyl phosphorylcholine)-based biodegradable nanogels for controlled drug release. Polym Chem. 2018;9:4556–65.

Article  CAS  Google Scholar 

Bae IH, Lim KS, Park JK, Park DS, Lee SY, Jang EJ, et al. Mechanical behavior and in vivo properties of newly designed bare metal stent for enhanced flexibility. J Ind Eng Chem. 2015;21:1295–300.

Article  CAS  Google Scholar 

Cho KH, Jeong MH, Park DS, Kim M, Kim J, Park JK, et al. Preclinical evaluation of a novel polymer-free Everolimus-Eluting stent in a mid-term porcine coronary restenosis model. J Korean Med Sci. 2021;36:e259.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahn YK, Jeong MH, Kim JW, Kim SH, Cho JH, Cho JG, et al. Preventive effects of the heparin-coated stent on restenosis in the porcine model. Catheter Cardiovasc Interv. 1999;48:324–30.

Article  CAS  PubMed  Google Scholar 

Schwartz RS, Edelman E, Virmani R, Carter A, Granada JF, Kaluza GL, et al. Drug-eluting stents in preclinical studies: updated consensus recommendations for preclinical evaluation. Circ Cardiovasc Interv. 2008;1:143–53.

Article  PubMed  PubMed Central  Google Scholar 

Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol. 1992;19:267–74.

Article  CAS  PubMed  Google Scholar 

Viele K, Berry S, Neuenschwander B, Amzal B, Chen F, Enas N, et al. Use of historical control data for assessing treatment effects in clinical trials. Pharm Stat. 2014;13:41–54.

Article  PubMed  Google Scholar 

Regar E, Sianos G, Serruys PW. Stent development and local drug delivery. Br Med Bull. 2001;59:227–48.

Article  CAS  PubMed  Google Scholar 

Shi W, Fuad ARM, Li Y, Wang Y, Huang J, Du R, et al. Biodegradable polymeric nanoparticles increase risk of cardiovascular diseases by inducing endothelium dysfunction and inflammation. J Nanobiotechnology. 2023;21:65.

Article  CAS  Google Scholar 

Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109:701–5.

Article  PubMed  Google Scholar 

Kastrati A, Mehilli J, Dirschinger J, Dotzer F, Schühlen H, Neumann FJ, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation. 2001;103:2816–21.

Article  CAS  PubMed  Google Scholar 

Pache J, Kastrati A, Mehilli J, Schühlen H, Dotzer F, Hausleiter J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol. 2003;41:1283–8.